SEC restatements

Sana Biotechnology, Inc. (SANA)

Sana Biotechnology, Inc. has 3 revised figures in later SEC filings: annual figures whose value in a later filing differs from the value on record first. Each revision below links to both filings.

CIK 0001770121

Annual figures revised
3
Latest filing stating a revision
Mar 3, 2026

Most recent revisions

Newest 3 of 3 · as filed · by the latest filing stating each revision

FigureOn record firstRevised
Depreciation & amortizationPeriod ended Dec 31, 2024$17.40MFiled Mar 17, 2025 (opens EDGAR in a new tab)$15.50MFiled Mar 3, 2026 (opens EDGAR in a new tab)
Depreciation & amortizationPeriod ended Dec 31, 2023$24.60MFiled Feb 29, 2024 (opens EDGAR in a new tab)$17.50MFiled Mar 3, 2026 (opens EDGAR in a new tab)
R&D expensePeriod ended Dec 31, 2023$268.82MFiled Feb 29, 2024 (opens EDGAR in a new tab)$261.81MFiled Mar 3, 2026 (opens EDGAR in a new tab)

A revised figure is not by itself a correction of an error. Companies re-present prior figures for ordinary reasons too, such as a discontinued business, a merger or a new accounting standard. The value on record first is the earliest filing we hold that states the figure; the revised value is the latest revised value on record, linked to the latest filing that states it.

Programmatic access

Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.

Every revised figure for this company, with both values and both filings (Analyst)
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/revisions/SANA

MCP tool: get_revisions ticker=SANA

Not investment advice. Figures are shown as filed with the SEC; each one links to the filing it came from.